R3 Vascular
Pre-clinicalR3 Vascular is developing a world-class Bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease.
Founded
2018
Focus
CardiovascularMedical Devices
About
R3 Vascular is developing a world-class Bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease.
Funding History
1Total raised: $20M
Series A$20MSands CapitalJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationSanta Clara, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile